Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia 13Leukemia, Myeloid, Acute 8Congenital Abnormalities 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Myelodysplastic Syndromes 2Neutropenia 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Anemia, Refractory, with Excess of Blasts 1

Interventions

merphos 1azathiopurine 1arsenous acid 1Tretinoin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Cytarabine 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Childhood Acute Promyelocytic Leukemia With PML-RARA × Idarubicin × Clear all
NCT00866918 2022-10-25

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Children's Oncology Group

Phase 3 Completed
106 enrolled 14 charts
MyeloidOther hematologic neoplasm

Childhood Acute Promyelocytic Leukemia With PML-RARA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡